Vital Therapies Receives $16,000,000 New Financing Round

  • Feed Type
  • Date
    9/28/2012
  • Company Name
    Vital Therapies
  • Mailing Address
    15222 Avenue of Science San Diego, CA 92128
  • Company Description
    Vital Therapies, Inc. (VTI) is a new company formed in 2003 to continue the development of the ELAD (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient’s liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix.
  • Website
    http://www.vitaltherapies.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The San Diego-based company plans to use the capital to run Phase III clinical trials of a product that combines liver cells with a medical device that could help people with acute liver failure.
  • M&A Terms
  • Venture Investor
    Undisclosed